)
)
Hansoh Pharmaceutical Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Hansoh Pharmaceutical Group
Access all reports
Hansoh Pharmaceutical Group is a Chinese pharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative and generic drugs. The company’s product portfolio covers therapeutic areas such as oncology, central nervous system (CNS) disorders, anti-infectives, and diabetes. Hansoh Pharmaceutical places a strong emphasis on innovation, investing in R&D to expand its pipeline with both novel and high-quality generic drugs to address unmet medical needs. The company is headquartered in Lianyungang, China, and its shares are listed on the Hong Kong Stock Exchange.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
3692
Country
🇭🇰 Hong Kong